SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK
38.40
07-二月-25 15:45:00
15 分钟延时
股票
-0.45
-1.16%
今日范围
38.14 - 38.92
ISIN
N/A
来源
NASDAQ
-
Supernus Announces Second Quarter 2024 Financial Results
06 8月 2024 15:06:00 条件 Nasdaq GlobeNewswire
-
Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
01 8月 2024 15:30:11 条件 Nasdaq GlobeNewswire
-
23 7月 2024 15:13:37 条件 Nasdaq GlobeNewswire
-
Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
30 5月 2024 15:25:33 条件 Nasdaq GlobeNewswire
-
23 5月 2024 15:05:48 条件 Nasdaq GlobeNewswire
-
09 5月 2024 15:05:39 条件 Nasdaq GlobeNewswire
-
Supernus Announces First Quarter 2024 Financial Results
08 5月 2024 15:05:50 条件 Nasdaq GlobeNewswire
-
Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story
01 5月 2024 07:00:32 条件 Nasdaq GlobeNewswire
-
24 4月 2024 15:05:53 条件 Nasdaq GlobeNewswire
-
Supernus Provides Regulatory Update for SPN-830
08 4月 2024 07:00:16 条件 Nasdaq GlobeNewswire
-
Supernus to Participate in Two Upcoming Investor Conferences
06 3月 2024 15:30:50 条件 Nasdaq GlobeNewswire
-
Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
28 2月 2024 15:30:04 条件 Nasdaq GlobeNewswire
-
Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
27 2月 2024 15:05:33 条件 Nasdaq GlobeNewswire
-
13 2月 2024 15:05:20 条件 Nasdaq GlobeNewswire
-
Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent
05 2月 2024 07:30:39 条件 Nasdaq GlobeNewswire
-
Supernus Announces Third Quarter 2023 Financial Results
08 11月 2023 15:05:44 条件 Nasdaq GlobeNewswire
-
Supernus to Participate in the Jefferies London Healthcare Conference
07 11月 2023 15:30:42 条件 Nasdaq GlobeNewswire
-
Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
02 11月 2023 06:00:05 条件 Nasdaq GlobeNewswire
-
25 10月 2023 15:15:32 条件 Nasdaq GlobeNewswire
-
16 10月 2023 16:34:21 条件 Nasdaq GlobeNewswire